Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Pollán, V. Lope, Josefa Miranda-García, Milagros García, Francisco Casanova, C. Sánchez-Contador, Carmen Santamariña, P. Moreo, C. Vidal, M. Peris, M. Moreno, José Vázquez-Carrete, F. Collado, Carmen Pedraz‐Pingarrón, N. Ascunce, Dolores Salas-Trejo, N. Aragonés, B. Pérez-Gómez, F. Ruiz-Perales (2012)Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain)
Breast Cancer Research and Treatment, 134
H. Fazilaty, P. Mehdipour (2014)Genetics of breast cancer bone metastasis: a sequential multistep pattern
Clinical & Experimental Metastasis, 31
M. Salhab, S. Bismohun, K. Mokbel (2010)Risk-reducing strategies for women carrying brca1/2 mutations with a focus on prophylactic surgery
BMC Women's Health, 10
B. Salhia, J. Kiefer, J. Ross, Raghu Metapally, Rae Martinez, Kyle Johnson, D. Diperna, Kimberly Paquette, Sungwon Jung, S. Nasser, G. Wallstrom, Waibhav Tembe, A. Baker, J. Carpten, J. Resau, T. Ryken, Z. Sibenaller, E. Petricoin, L. Liotta, R. Ramanathan, M. Berens, N. Tran (2014)Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis
PLoS ONE, 9
Abigail Hoffman, Rod Pellenberg, Catherine Drendall, V. Seewaldt (2012)Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer
Current Breast Cancer Reports, 4
Xin-hong Wu, Bo Luo, Shaozhong Wei, Yan Luo, Yao-jun Feng, Juan Xu, Wei Wei (2013)Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple-negative breast cancer.
Journal of cancer research and therapeutics, 9 Suppl
L. Vona-Davis, D. Rose, V. Gadiyaram, B. Ducatman, G. Hobbs, H. Hazard, S. Kurian, J. Abraham (2014)Breast Cancer Pathology, Receptor Status, and Patterns of Metastasis in a Rural Appalachian Population
Journal of Cancer Epidemiology, 2014
R. Aft, M. Naughton, Kathryn Trinkaus, K. Weilbaecher (2012)Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
British Journal of Cancer, 107
P. Møller (2004)Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer
Hereditary Cancer in Clinical Practice, 2
O. Bougie, J. Weberpals (2011)Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
International Journal of Surgical Oncology, 2011
P. Bendinelli, P. Maroni, E. Matteucci, A. Luzzati, G. Perrucchini, M. Desiderio (2014)Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
Biochimica et biophysica acta, 1843 4
A. Saha, S. Ghosh, C. Roy, K. Choudhury, B. Chakrabarty, Ratan Sarkar (2013)Demographic and clinical profile of patients with brain metastases: A retrospective study
Asian Journal of Neurosurgery, 8
Amanda Smolarek, N. Suh (2011)Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol
B. Pięta, K. Chmaj-Wierzchowska, T. Opala (2012)Life style and risk of development of breast and ovarian cancer.
Annals of agricultural and environmental medicine : AAEM, 19 3
M. Gil-Gil, bullet Martinez-Garcia, bullet Sierra, bullet Conesa, bullet Barco, bullet González-Jimenez, bullet Villà (2013)Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline
Clinical & Translational Oncology, 16
J. Litton, T. Bevers, B. Arun (2012)Exemestane in the prevention setting
Therapeutic Advances in Medical Oncology, 4
A. Khanfir, F. Lahiani, Racem Bouzguenda, I. Ayedi, J. Daoud, M. Frikha (2013)Prognostic factors and survival in metastatic breast cancer: A single institution experience.
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 18 3
R. Roetzheim, J. Ferrante, J. Lee, Ren Chen, Kymia Love-Jackson, E. Gonzalez, K. Fisher, E. McCarthy (2012)Influence of Primary Care on Breast Cancer Outcomes Among Medicare Beneficiaries
The Annals of Family Medicine, 10
M. Cazzaniga, C. Varricchio, C. Montefrancesco, I. Feroce, A. Guerrieri-Gonzaga (2012)Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?
Journal of Biomedicine and Biotechnology, 2012
D. Hunter, G. Colditz, S. Hankinson, S. Malspeis, D. Spiegelman, Wendy Chen, M. Stampfer, W. Willett (2010)Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
Cancer Epidemiology, Biomarkers & Prevention, 19
S. Mohr, E. Gorham, J. Alcaraz, C. Kane, C. Macera, J. Parsons, D. Wingard, C. Garland (2012)Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?
F. Xue, W. Willett, B. Rosner, S. Hankinson, K. Michels (2011)Cigarette smoking and the incidence of breast cancer.
Archives of internal medicine, 171 2
H. Nelson, L. Huffman, R. Fu, E. Harris (2005)Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force
Annals of Internal Medicine, 143
Y. Huang, M. Kang, H. Li, J. Li, J. Zhang, L. Liu, X. Liu, Y. Zhao, Q. Wang, C. Li, H. Lee (2012)Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: a follow-up study.
Current oncology, 19 Suppl 2
I. Flores, Alan Santos-Silva, R. Coletta, P. Vargas, M. Lopes (2014)Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis.
Oral surgery, oral medicine, oral pathology and oral radiology, 117 3
Chao Qin, Bing He, Wenbing Dai, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Guangji Wang, Lifang Yin, Qiang Zhang (2014)Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
Molecular pharmaceutics, 11 10
L. Kobayashi, Heather Limburg, Q. Miao, C. Woolcott, L. Bedard, T. Massey, K. Aronson (2012)Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions
Frontiers in Oncology, 2
S. Bersini, J. Jeon, G. Dubini, C. Arrigoni, Seok Chung, J. Charest, M. Moretti, R. Kamm (2014)A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone.
Biomaterials, 35 8
J. Do, Deshka Foster, Corinne Renier, H. Vogel, S. Rosenblum, T. Doyle, V. Tse, I. Wapnir (2014)Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models
Breast Cancer Research and Treatment, 144
A. Coviello, R. Haring, M. Wellons, Dhananjay Vaidya, T. Lehtimäki, S. Keildson, K. Lunetta, Chunyan He, M. Fornage, V. Lagou, M. Mangino, N. Onland-Moret, Brian Chen, J. Eriksson, M. Garcia, Yong Liu, A. Koster, K. Lohman, L. Lyytikäinen, A. Petersen, J. Prescott, L. Stolk, L. Vandenput, A. Wood, Z. Wei, A. Ruokonen, A. Hartikainen, A. Pouta, S. Bandinelli, R. Biffar, G. Brabant, D. Cox, Yuhui Chen, S. Cummings, L. Ferrucci, M. Gunter, S. Hankinson, H. Martikainen, A. Hofman, G. Homuth, T. Illig, J. Jansson, Andrew Johnson, D. Karasik, M. Karlsson, J. Kettunen, D. Kiel, P. Kraft, Jingmin Liu, Ö. Ljunggren, M. Lorentzon, M. Maggio, M. Markus, D. Mellström, I. Miljkovic, D. Mirel, Sarah Nelson, Laure Papunen, P. Peeters, I. Prokopenko, L. Raffel, M. Reincke, A. Reiner, K. Rexrode, F. Rivadeneira, S. Schwartz, D. Siscovick, N. Soranzo, D. Stöckl, S. Tworoger, A. Uitterlinden, C. Gils, R. Vasan, H. Wichmann, G. Zhai, S. Bhasin, M. Bidlingmaier, S. Chanock, I. Vivo, T. Harris, D. Hunter, M. Kähönen, Simin Liu, P. Ouyang, T. Spector, Y. Schouw, J. Viikari, H. Wallaschofski, M. McCarthy, T. Frayling, A. Murray, S. Franks, M. Järvelin, F. Jong, O. Raitakari, A. Teumer, C. Ohlsson, J. Murabito, J. Perry (2012)A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation
PLoS Genetics, 8
P. Pasanisi, G. Hédelin, J. Berrino, J. Chang-Claude, S. Hermann, M. Steel, N. Haites, J. Hart, R. Peled, L. Gafà, Laura Leggio, A. Traina, R. Amodio, M. Primic‐Žakelj, V. Zadnik, T. Veidebaum, M. Tekkel, F. Berrino (2009)Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study
Cancer Epidemiology Biomarkers & Prevention, 18
R. Siegel, C. DeSantis, Katherine Virgo, K. Stein, A. Mariotto, Tenbroeck Smith, D. Cooper, T. Gansler, C. Lerro, S. Fedewa, C. Lin, C. Leach, Rachel Cannady, Hyunsoon Cho, S. Scoppa, Mark Hachey, Rebecca Kirch, A. Jemal, Elizabeth Ward (2012)Cancer treatment and survivorship statistics, 2012
CA: A Cancer Journal for Clinicians, 62
Se Park, Hyun-Jeong Kim, K. Kim, S. Lee, C. Lee, Kwang-Kyun Park, W. Chung (2014)Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.
Toxicology and applied pharmacology, 275 2
[A large percentage of Americans are plagued by cancer. In the United States, one third of females and one half of males face the condition sometime in their lifetime. One type of cancer that has adversely impacted the lives of many on a multinational scale is breast cancer (BC). In order to effectively battle and prevent the condition of BC, it is critical to obtain a better understanding of the biology of BC and its metastases. An important step to gain better understanding is by studying risk factors. Under this category, it is important to consider both occupational hazards and genetic predispositions. Additionally, drugs are ever-important in the fight against any disease. In the fight against BC, it is important to be aware of new drugs for BC prevention and cure. However, older drugs should not be disregarded, and thus, studies should continue to search for new information concerning their side effects and uses. Lastly, since 90 % of cancer deaths occur due to metastases, this aspect of cancer cannot be disregarded. Prevention and treatment methods for BC metastases must also be considered. Thus, this article will represent discussion on risk factors, information about new and existent drugs, and treatment and prevention for BC metastases, especially to bones and the brain. This article will also discuss new ways to synergize existing conventional drugs and preventive technologies in order to achieve optimal management strategies for eradicating BC.]
Published: Sep 6, 2014
Keywords: Breast cancer; Cancer epidemiology; Prevention; Treatment; Metastases
Access the full text.
Sign up today, get DeepDyve free for 14 days.